esorubicin has been researched along with Leucocythaemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raymond, V; Young, CW | 1 |
| Allen, SL; Budman, DR; Chan, K; Kreis, W; Rottach, C; Schulman, P; Vinciguerra, V; Weiselberg, L | 1 |
1 review(s) available for esorubicin and Leucocythaemia
| Article | Year |
|---|---|
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Topics: Aclarubicin; Anthraquinones; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cell Survival; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Leukemia; Menogaril; Mitoxantrone; Naphthacenes; Nogalamycin; Sarcoma; Structure-Activity Relationship | 1986 |
1 other study(ies) available for esorubicin and Leucocythaemia
| Article | Year |
|---|---|
Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemia.
Topics: Doxorubicin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myeloid, Acute; Male; Metabolic Clearance Rate | 1988 |